Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Genet Epidemiol. 2016 Jun 17;40(6):461–469. doi: 10.1002/gepi.21983

Table IV.

Annotation and marginal BFs for RVs with BF>10 in the post-hoc analysis of 438 RVs implicated in pathway RV analysis in prostate cancer risk.

Chr Position Gene Ref Alt Effect BF
15 42,364,046 PLA2G4D T C Missense 22.5
15 42,439,921 PLA2G4F G C Nonsense 82.9
15 42,448,635 PLA2G4F A C Splice-site 2787.7
22 38,559,586 PLA2G6 G C Intronic 11.6